Capnat (Capecitabine) – Patient Information (Australia)

Capnat contains capecitabine, a chemotherapy medicine used to treat several types of cancer. This guide is written to help you understand what the medicine does, how it is taken, what to expect, and how to reduce common risks. Always follow your treating team’s instructions and the product information provided with your medicine.

Basic product information

• Brand name: Capnat
• Generic name: Capecitabine
• Dosage forms: Tablets (strengths vary by product)
• Storage: Keep tablets at room temperature, protected from moisture and out of reach of children (follow packaging instructions).
• Handling: If tablets break or you handle them while bare-handed, wash your hands. Keep away from children and pets.

How capecitabine works (mechanism of action)

Capecitabine is a prodrug. This means it is converted within the body into its active form. The final active drug works mainly by:

• Interfering with DNA synthesis: It inhibits key steps needed for cancer cells to grow and divide.
• Targeting tumour activity: Conversion to active 5‑FU occurs more in tumour tissues than in normal tissues, which can help reduce—but not eliminate—side effects.
• Disrupting RNA and cell replication: This makes it harder for rapidly dividing cells (including many cancer cells) to multiply.

Pharmacokinetics (how the body processes it)

Understanding pharmacokinetics can help explain timing and side effects. Key points include:

• Absorption: Capecitabine is absorbed after oral administration, with food improving tolerability and reducing variability in absorption.
• Metabolism: It is metabolised through several steps to produce 5‑fluorouracil (5‑FU) and related metabolites.
• Distribution: Active metabolites distribute throughout the body and are processed further in tissues.
• Elimination: Metabolites are mainly cleared by the body through renal (kidney) pathways. This is important for people with kidney impairment.
• Half-life (general concept): The drug and its active metabolites are eliminated over hours to days; exact timing depends on patient factors and kidney function.

Kidney and liver function matter: Because clearance involves metabolism and renal elimination, your clinician may adjust the dose if kidney function is reduced.

Typical uses (indications)

Capecitabine is used for several cancers. Common indications include (depending on treatment plan and local guidelines):

• Breast cancer: Certain stages or settings, including adjuvant treatment or metastatic disease, often guided by tumour markers and prior therapies.
• Colorectal cancer: Including metastatic disease and some adjuvant or combination regimens.
• Gastro-oesophageal cancers: In some settings, including gastric (stomach) or gastro‑oesophageal junction cancers.
• Other specific cancers and combinations: Sometimes used with other medicines as part of combination chemotherapy plans.

Which exact indication applies to you depends on your cancer type, stage, previous treatments, and your overall health. Your treating team will specify the goal (for example, to control growth, shrink tumours, or reduce recurrence risk).

Dosing and timing (how it is usually taken)

Capecitabine is usually taken as tablets by mouth on a schedule defined by your treatment cycle. Many regimens follow a pattern such as:

• Twice daily dosing
• Days on treatment followed by rest days (for example, a 14‑day course followed by a 7‑day break, repeated in cycles—your schedule may differ)

Important: Your exact dose (mg) and cycle schedule can vary. Always follow the dose instructions provided by your clinician and the medicine label.

How to take it

• Take with food: Take capecitabine after meals (after breakfast and after dinner/snack), unless your clinician instructs otherwise.
• Swallow tablets whole: Do not crush, split, or chew unless directed by your clinical team.
• Take at consistent times: Keeping similar time gaps each day helps maintain steady exposure.
• Do not double up: If you miss a dose, do not take extra tablets to compensate unless advised by your treating team. (See the FAQ for a practical approach.)

Timing with meals (food interaction)

Food plays an important role:

• Recommended: Take after meals to improve absorption and tolerability.
• Avoid taking on an empty stomach: Doing so may increase gastrointestinal side effects or change how the medicine is absorbed.
• Maintain routine: Try to keep breakfast and dinner timing consistent during treatment days.

Food interactions

For most people, the main food-related rule is straightforward: take capecitabine after meals.

Beyond meal timing:

• Alcoholic beverages: Not a direct food “interaction,” but alcohol can worsen dehydration and may increase risk of side effects such as nausea or diarrhoea (details below).
• Grapefruit and herbal products: There is no universal capecitabine-specific grapefruit rule, but herbal supplements can affect metabolism and tolerability. Check with your pharmacist before starting new supplements.
• Stomach upset: If you experience nausea, use your clinician’s advice on meal size and hydration strategies.

Alcohol and medicine interactions

Alcohol: While there is not always a strict “absolute” prohibition, it is generally recommended to avoid or minimise alcohol during chemotherapy because:

• It can aggravate nausea and diarrhoea.
• It may worsen dehydration, which increases risk of complications during treatment.
• It may affect liver function and overall tolerance of medicines.

Medicine interactions: Interactions can occur because capecitabine is metabolised through multiple pathways, and because chemotherapy can change blood counts and organ tolerance.

Examples of commonly relevant interaction categories:

• Warfarin and similar blood thinners: Capecitabine may increase bleeding risk by affecting how warfarin works. Close monitoring (e.g., INR checks) is often required.
• Phenytoin: May cause levels to change, increasing toxicity or reducing effectiveness.
• Folic acid supplements: These may potentially influence effects; ask your clinician before routine high-dose folic acid during treatment.
• Allopurinol: Can interact with dosing and metabolism in some chemotherapy contexts.
• Antacids and acid-reducing medicines: Some combinations may alter tolerability or absorption; your pharmacist can check your specific regimen.
• Other chemotherapy or radiotherapy: Combination treatment increases the importance of monitoring and dose adjustments.

Best practice: Keep an up-to-date list of all medicines, including prescription medicines, over-the-counter products, vitamins, and herbal supplements. Share it with your pharmacist or treating team before starting any new item.

Safety profile and side effects

Like all cancer medicines, capecitabine can cause side effects. Many are manageable, especially with early reporting and dose adjustments. Side effects vary by person and by dose.

Common side effects

• Diarrhoea or bowel changes
• Nausea, loss of appetite, or indigestion
• Vomiting (less common than nausea)
• Hand–foot syndrome (palmar-plantar erythrodysesthesia): redness, pain, swelling, tingling or peeling of skin on hands/feet
• Fatigue
• Stomatitis: mouth sores
• Rash or dry skin
• Changes in taste

Potentially serious side effects (seek urgent medical advice)

Contact your treating team urgently or seek emergency care if you experience:

• Fever (especially if your white blood cell count may be low)
• Severe diarrhoea (for example, frequent watery stools) or signs of dehydration (dizziness, very low urine output)
• Severe mouth sores that prevent drinking or eating
• Shortness of breath, chest pain, or unusual bleeding/bruising
• Allergic reaction symptoms (swelling of face/lips, wheezing, widespread rash with breathing difficulty)
• Uncontrolled vomiting or inability to keep fluids down

Blood count and organ monitoring

During treatment, clinicians typically monitor:

• Full blood counts (white cells, red cells, platelets)
• Kidney function (creatinine/eGFR)
• Liver function tests
• Electrolytes if you have diarrhoea or vomiting

Lab results may lead to dose reductions or pauses to keep you safe.

Practical use tips (patient-friendly)

• Hydration: Drink fluids regularly unless your clinician has restricted fluids. Diarrhoea and mouth sores increase fluid needs.
• Track symptoms: Keep a simple diary of bowel frequency, temperature, mouth pain, and any skin changes to report early.
• Hand–foot prevention: Use moisturisers, avoid friction, and protect hands/feet during treatment (comfortable shoes, gloves for chores). Avoid hot water on hands/feet.
• Oral care: Rinse mouth gently, avoid alcohol-based mouthwashes if they burn, and report mouth sores early.
• Skin care: Use gentle soaps, avoid harsh scrubs, and wear sunscreen when outdoors.
• Plan meal timing: Because doses are after meals, prepare your routine so you can eat even if appetite is reduced (small frequent meals may help).
• Medication management: Use a pill organiser if your regimen allows it, and double-check tablet strengths before each dose.
• Pregnancy prevention: Capecitabine can harm an unborn baby. Discuss contraception and family planning with your healthcare team.
• Breastfeeding: Breastfeeding should be discussed with your clinician before use.

Missed dose guidance (general)

If you miss a dose, follow the plan provided by your treating team or the product guidance. In general, many chemotherapy regimens recommend:

• Do not take extra tablets to make up for the missed dose.
• Contact your clinician or pharmacist for personalised instructions, especially if you miss multiple doses.

Because timing and dose adjustments can be cycle-specific, the safest approach is to ask your pharmacist for advice tailored to your schedule.

Alternative options

Depending on your cancer type, stage, and previous treatment history, alternative options may include:

• Other oral chemotherapy agents
• Intravenous chemotherapy regimens
• Targeted therapies for specific tumour biomarkers
• Immunotherapy in selected cancers
• Radiotherapy in combination with systemic treatment

Your treating team may select capecitabine specifically because of the cancer type, convenience of oral dosing, expected benefits, and your health status. If capecitabine is not suitable, alternatives will be considered.

Market and legal context for Australia (overview)

In Australia, chemotherapy medicines are regulated under the Therapeutic Goods Act and related frameworks overseen by Australian Government regulatory bodies, including Therapeutic Goods Administration (TGA) for medicines approval and quality.

Medicines like capecitabine are dispensed through appropriate channels, and supply may involve:

• Authorised prescribing and dispensing workflows
• Pharmacist counselling on safe handling, administration, and side-effect monitoring
• Batch quality controls and regulated storage/transport requirements
• Patient education materials included with supply

Availability, brand choice, and pack sizes can vary. Your pharmacy can confirm what is currently in stock.

Recent guidance and safety updates (general)

Guidance for capecitabine use can evolve with emerging clinical evidence. In Australia, treatment decisions are typically supported by:

• Clinical practice guidelines from cancer societies and specialist bodies
• Safety communications related to chemotherapy use and risk management
• Ongoing monitoring recommendations to reduce severe side effects (for example, prompt diarrhoea management)

If your treatment plan changes or you experience new symptoms, ask your treating team whether there are any updated instructions for your cycle.

Delivery and availability

Availability of Capnat (capecitabine) tablets may vary based on supply chain schedules and approved pack sizes. When ordering from an online pharmacy in Australia:

• Stock confirmation: Most pharmacies will confirm availability before dispatch.
• Packaging: Medicines are typically shipped in secure, tamper-evident packaging.
• Cold-chain: Capecitabine tablets generally do not require cold storage (confirm on the pack).
• Delivery times: Standard and express options may be offered depending on location. Delivery can be delayed due to peak periods.

Tip: If you are near the start of a new treatment cycle, place orders early to allow time for dispensing and delivery.

FAQ

1) What is Capnat used for?

Capnat (capecitabine) is used to treat certain cancers, often as part of a structured chemotherapy regimen. The exact indication depends on your diagnosis and treatment plan.

2) How should I take capecitabine each day?

Most schedules involve taking tablets twice daily, after meals (for example, after breakfast and after dinner). Take tablets exactly as directed on your medicine label.

3) What should I do if I vomit after taking a dose?

If you vomit shortly after a dose, it may not be clear whether the full amount was absorbed. Do not take an extra dose unless your clinician or pharmacist instructs you. Contact your healthcare team for advice.

4) What if I miss a dose?

Follow the specific instructions provided with your treatment plan. In many chemotherapy schedules, you should not double up. Because timing varies by cycle, contact your pharmacy or treating team for personalised guidance.

5) How long does a treatment cycle last?

Cycles vary depending on the cancer type and regimen. Many involve days on treatment followed by rest days. Your clinician will tell you the exact cycle length.

6) What is hand–foot syndrome, and how can I reduce it?

Hand–foot syndrome is a common capecitabine side effect involving redness, pain, swelling, tingling, or peeling on the hands and feet. To reduce risk: moisturise regularly, avoid friction and hot water, wear protective gloves for chores, and report symptoms early so your dose can be adjusted if needed.

7) Can I take pain relief or anti-nausea medicines?

Many supportive medicines can be used, but not all are suitable for everyone. Tell your pharmacist about all medicines you plan to take, including “over-the-counter” products and supplements. Your clinician may prescribe anti-nausea medicine and advise what’s safe for you.

8) Is alcohol allowed?

It’s generally best to avoid or minimise alcohol during chemotherapy, especially if you have nausea, diarrhoea, mouth sores, or dehydration. Ask your clinician if you have specific questions based on your health and other medicines.

9) Are there dietary restrictions?

There are no universal dietary bans, but you should take each dose after meals and stay hydrated. If you experience diarrhoea or mouth sores, your clinician may suggest specific food and fluid strategies.

10) When should I seek urgent medical help?

Seek urgent medical advice if you have fever, severe diarrhoea, signs of dehydration, uncontrolled vomiting, significant bleeding/bruising, breathing problems, or signs of an allergic reaction.

Summary

Capnat (capecitabine) is an oral chemotherapy medicine that works by disrupting how cancer cells make DNA and multiply. It is typically taken after meals on a cycle schedule, with careful monitoring for side effects and blood/organ function. If you report symptoms early—especially diarrhoea, mouth sores, and hand–foot symptoms—your healthcare team can adjust treatment to improve safety and comfort.

If you have questions about your dosing schedule, interactions, or managing side effects, speak with your pharmacist or treating team.